Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Cystatin-C C-guided Vancomycin Dosing Recommendation on Target Trough Achievement and Clinical Outcomes in Critically Ill Adults

NCT02945241 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02945241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02945241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Cystatin-C C-guided Vancomycin Dosing Recommendation on Target Trough Achievement and Clinical Outcomes in Critically Ill Adults
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2014
Completion date
March 31, 2016
Enrollment
399 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness, methicillin-resistant staphylococcus aureus, sepsis